NONOF - Novo Nordisk A/S

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue111,696,000111,780,000107,927,00088,806,000
Cost of Revenue17,632,00017,183,00016,188,00014,562,000
Gross Profit94,064,00094,597,00091,739,00074,244,000
Operating Expenses
Research Development13,819,00014,147,00013,608,00013,762,000
Selling General and Administrative32,124,00032,339,00032,169,00026,760,000
Non Recurring----
Others-1,041,000-737,000-657,000-770,000
Total Operating Expenses62,534,00062,932,00061,308,00054,314,000
Operating Income or Loss49,162,00048,848,00046,619,00034,492,000
Income from Continuing Operations
Total Other Income/Expenses Net-482,000-1,050,000-3,136,000-396,000
Earnings Before Interest and Taxes49,162,00048,848,00046,619,00034,492,000
Interest Expense-90,000-65,000-67,000-39,000
Income Before Tax48,680,00047,798,00043,483,00034,096,000
Income Tax Expense10,550,0009,873,0008,623,0007,615,000
Minority Interest----
Net Income From Continuing Ops38,130,00037,925,00034,860,00026,481,000
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income38,130,00037,925,00034,860,00026,481,000
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares38,130,00037,925,00034,860,00026,481,000